In "Generic SGLT2 Inhibitors and Interpreting Divergent CKD Trial Data," Dr. Haumschild turns to generic tiering strategy and ...

Tennessee Oncology's Wade Iams, MD, MSCI, discusses staffing and tocilizumab access as barriers to expanding BiTE therapy and ...

Diagnostic delays in narcolepsy and idiopathic hypersomnia (IH) persist largely because of low awareness among patients, ...

ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports ...

Welcome back to another AJMC Stakeholder Summit series. In "Vitiligo Prevalence and Why It Isn't Cosmetic," moderator Susan ...

"Setting Realistic Asthma Treatment Goals Across Diverse Patient Populations" features a candid exchange about how practice setting shapes what clinicians can realistically aim for.

Experts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order ...

Intensive blood pressure (BP) lowering reduced the risk of major cardiovascular events by 15% for every 10-mm Hg reduction in ...

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...

The FDA approved phentolamine ophthalmic solution 0.75% (Ryzumvi; Viatris) for the treatment of presbyopia in adults, giving ...

FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...